ROR1 and non-small cell lung carcinoma: Treatment with ARI-1 blocked downstream ROR1 signaling via PI3K/AKT/mTOR, thus inhibiting proliferation and migration of ROR1-positive non-small cell lung cancer cells in vitro and in vivo.